1. Adler, Arnon, Novelli, Valeria, Amin, Ahmad S, Wilde, Arthur A M, Gollob, Michael H. 2020. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. In Circulation, 141, 418-428. doi:10.1161/CIRCULATIONAHA.119.043132. https://pubmed.ncbi.nlm.nih.gov/31983240/
2. He, Jie, Ni, Zhijie, Li, Zhongbo. . CALM3 affects the prognosis of leukemia and hemorrhoids. In Medicine, 102, e36027. doi:10.1097/MD.0000000000036027. https://pubmed.ncbi.nlm.nih.gov/37932969/
3. Hamrick, Samantha K, Kim, C S John, Tester, David J, Gluscevic, Martina, Ackerman, Michael J. 2024. Single Construct Suppression and Replacement Gene Therapy for the Treatment of All CALM1-, CALM2-, and CALM3-Mediated Arrhythmia Disorders. In Circulation. Arrhythmia and electrophysiology, 17, e012036. doi:10.1161/CIRCEP.123.012036. https://pubmed.ncbi.nlm.nih.gov/39069900/
4. Zhou, Qiu-Hong, Zhao, Lan-Juan, Wang, Ping, Ye, An, Zhou, Bo-Ting. 2014. Comprehensive analysis of the association of EGFR, CALM3 and SMARCD1 gene polymorphisms with BMD in Caucasian women. In PloS one, 9, e112358. doi:10.1371/journal.pone.0112358. https://pubmed.ncbi.nlm.nih.gov/25396734/
5. Bortolin, Raul H, Nawar, Farina, Park, Chaehyoung, Bezzerides, Vassilios J, Pu, William T. 2024. Antisense Oligonucleotide Therapy for Calmodulinopathy. In Circulation, 150, 1199-1210. doi:10.1161/CIRCULATIONAHA.123.068111. https://pubmed.ncbi.nlm.nih.gov/39155863/